In non-ICU subjects, the treatment success rate was significantly higher among subjects receiving micafungin than liposomal amphotericin B (85% versus 72.1%; P = 0.0113).
micafungin (100 mg/day for subjects > 40 kg; 2 mg/kg/day for subjects ≤ 40 kg)
liposomal amphotericin B (3 mg/kg/day)
treatment success in non-ICU subjects